Access cutting-edge alcohol use disorder treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access alcohol use disorder specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alcohol use disorder treatment provided free
The investigators assess whether guanfacine extended release (GXR; 3mg/d) compared with placebo (PBO) will attenuate drinking and drinking-related factors in N=200 men and women with Alcohol Use Disorder (AUD) across 12-weeks.
Sponsor: Indiana University
Check if you qualify for this alcohol use disorder clinical trial in Indianapolis, IN
If you're searching for alcohol use disorder treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alcohol use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.